Your session is about to expire
← Back to Search
Behavioural Intervention
Supportive Care Intervention for Caregivers of Adults With Cancer
N/A
Waitlist Available
Led By Sindhuja Kadambi
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks per patient
Awards & highlights
Study Summary
This trialwill assess if a geriatric assessment can identify older cancer caregivers in need of extra support, and create a plan to help them.
Who is the study for?
This trial is for older adults aged 65+ who are caregivers to other older adults with advanced cancer. Participants must be able to give informed consent or have a pre-existing health care proxy if unable to do so. It includes patients starting new treatments and healthcare professionals experienced in geriatric oncology.Check my eligibility
What is being tested?
The study tests the use of a geriatric assessment tool aimed at identifying distress in caregivers. It involves Delphi Surveys, Focus Groups, and Qualitative interviews with stakeholders like caregivers, experts in geriatric oncology, and primary care physicians.See study design
What are the potential side effects?
Since this trial focuses on supportive care interventions rather than medical treatments, traditional side effects associated with medications are not applicable here.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 8 weeks per patient
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks per patient
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Caregiver satisfaction with completing the GA
Percentage of participants who enroll and complete the GA
Time for caregivers to complete the GA
Secondary outcome measures
Percentage of caregiver supportive care recommendations that are implemented by patient/caregiver physicians
Trial Design
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment3 Interventions
Participants will receive a geriatric assessment which consists of validated questionnaires that are used to assess health status of older adults with cancer. Based on participant responses, tailored recommendations will be provided.
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
838 Previous Clinical Trials
518,494 Total Patients Enrolled
Sindhuja KadambiPrincipal InvestigatorUniv. of Rochester Wilmot Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have not started a new treatment for your medical condition recently.
Research Study Groups:
This trial has the following groups:- Group 1: Experimental
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger